LISATA THERAPEUTICS, INC. Logo

LISATA THERAPEUTICS, INC.

Develops therapies to enhance anti-cancer drug delivery to solid tumors.

LSTA | US

Overview

Corporate Details

ISIN(s):
US1280583022 (+1 more)
LEI:
Country:
United States of America
Address:
110 ALLEN ROAD, 7920 BASKING RIDGE

Description

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 17:16
10-Q
English 1.9 MB
2025-11-06 17:10
8-K
English 17.4 MB
2025-10-14 18:02
8-K
English 15.4 MB
2025-10-08 17:12
8-K
English 58.4 KB
2025-08-07 18:13
10-Q
English 26.4 MB
2025-08-07 18:09
8-K
English 15.9 MB
2025-07-15 10:00
8-K
English 759.7 KB
2025-06-26 10:38
8-K
English 17.8 MB
2025-06-17 11:13
8-K
English 14.7 MB
2025-06-13 18:02
8-K
English 24.5 MB
2025-06-10 18:03
8-K
English 57.7 KB
2025-05-08 18:14
10-Q
English 2.1 MB
2025-05-08 18:07
8-K
English 12.7 MB
2025-04-25 18:12
DEFA14A
English 12.6 MB
2025-04-25 18:10
DEF 14A
English 16.8 MB

Automate Your Workflow. Get a real-time feed of all LISATA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LISATA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LISATA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.